Postoperative Analgesia With an Erector Spinae Plane Block in Robotic-assisted Partial Nephrectomy
ESBPblock
Providing Postoperative Analgesia With an Erector Spinae Plane Block in Robotic-assisted Partial Nephrectomy
1 other identifier
interventional
46
1 country
1
Brief Summary
Partial nephrectomy is used as a standard method for the treatment of T1 kidney tumors, while radical nephrectomy is preferred for T2 tumors and localized masses that cannot be treated with partial nephrectomy. These surgical procedures can be performed using open surgery, laparoscopic, or robotic approaches. Open surgical methods, especially during partial or radical nephrectomy, generally require wide incisions extending below the costal arch. These incisions involve cutting through intercostal muscle structures, fascial layers, and subcutaneous tissues, which can lead to significant postoperative discomfort for the patient. This situation can directly affect the patient's comfort and recovery time. This study aims to investigate the effect of the erector spinae plane block, a method we routinely use for analgesic purposes in many procedures in anesthesia practice, on postoperative pain levels, analgesic consumption, patient satisfaction, and length of stay after robotic-assisted partial nephrectomy surgery. Method: Patients ranging in age between 18 and 70 were randomly assigned to either Group 1 (ESPB 30 ml bupivacaine 0.25%) or Group 2 (Control)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2025
CompletedFirst Posted
Study publicly available on registry
April 15, 2025
CompletedStudy Start
First participant enrolled
May 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2025
CompletedDecember 19, 2025
December 1, 2025
3 months
March 24, 2025
December 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reducing patient-controlled analgesic consumption
The amount of analgesic consumption first 24 hours in the postoperative period
From the patient's anesthesia induction in the operating room to the postoperative 24. hours
Secondary Outcomes (1)
the satisfaction of the surgeon and the patient during the postoperative period
From the patient's anesthesia ending to the postoperative 24. hours
Study Arms (2)
ESPB group
ACTIVE COMPARATORReceiving ESPB 30 ml bupivacaine 0.25%
control group
ACTIVE COMPARATORNot receiving ESBP
Interventions
The Erector Spinae Plane Block (ESPB) is a technically simple and safe form of regional anesthesia that can provide effective analgesia for 12 hours in patients with acute postoperative pain
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) Class I or II
- Having regular preoperative visits
- Pregnant aged 18-70
You may not qualify if:
- Patients classified as ASA III or IV,
- Patients with cardiopulmonary difficulties,
- Patients who have previously been diagnosed with diabetes,
- Conditions requiring emergency surgery,
- Patients who refuse to participate in the study,
- Individuals with contraindications for general anesthesia,
- Patients who weighed less than 50 kg or more than 110 kg.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kudret Doğru
Kayseri, 38050, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kudret Doğru
TC Erciyes University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
March 24, 2025
First Posted
April 15, 2025
Study Start
May 15, 2025
Primary Completion
August 15, 2025
Study Completion
November 15, 2025
Last Updated
December 19, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share